Federal health officials have announced a delay in expanding COVID-19 vaccine recommendations for children under five, citing the need for additional review of safety data from clinical trials. The decision follows recent concerns raised by an independent advisory panel about potential risks linked to the vaccines. Parents and pediatricians are left awaiting further guidance as the timeline for widespread vaccination remains uncertain. The pause highlights ongoing debates over balancing vaccine efficacy with rare but serious side effects in young children.
Covid Vaccines Delayed for Half of U.S. Children The New York Times
